These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34156518)

  • 1. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
    Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
    Sasagawa Y; Tachibana O; Nakagawa A; Koya D; Iizuka H
    J Clin Neurosci; 2015 Mar; 22(3):601-3. PubMed ID: 25455737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary apoplexy after leuprolide.
    Davis A; Goel S; Picolos M; Wang M; Lavis V
    Pituitary; 2006; 9(3):263-5. PubMed ID: 16832587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].
    Hernandez Morin N; Huet D; Hautecouverture M
    Ann Endocrinol (Paris); 2003 Jun; 64(3):227-31. PubMed ID: 12910066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Pituitary Apoplexy Following Leuprolide Injection for Prostate Cancer.
    Kim KW; Chee S; Sunkara N; Baker MH
    R I Med J (2013); 2024 Feb; 107(2):7-9. PubMed ID: 38285742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.
    Huang TY; Lin JP; Lieu AS; Chen YT; Chen HS; Jang MY; Shen JT; Wu WJ; Huang SP; Juan YS
    World J Surg Oncol; 2013 Oct; 11():254. PubMed ID: 24088191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary apoplexy after leuprolide administration for carcinoma of the prostate.
    Morsi A; Jamal S; Silverberg JD
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):121-4. PubMed ID: 8706284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset of pituitary apoplexy following gonadotropin-releasing hormone agonist for prostate cancer treatment.
    Elshimy G; Raj R; Jacob A; Correa R
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35256375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
    Sinnadurai M; Cherukuri RK; Moses RG; Nasser E
    J Clin Neurosci; 2010 Sep; 17(9):1201-3. PubMed ID: 20605467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.
    Tanios G; Mungo NA; Kapila A; Bajaj K
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist-induced pituitary apoplexy in treatment of prostate cancer: case report and review of literature.
    Hands KE; Alvarez A; Bruder JM
    Endocr Pract; 2007 Oct; 13(6):642-6. PubMed ID: 17954421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.
    Barbosa M; Paredes S; Machado MJ; Almeida R; Marques O
    Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
    Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
    Int J Urol; 2006 Mar; 13(3):303-4. PubMed ID: 16643633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
    Masson EA; Atkin SL; Diver M; White MC
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):109-10. PubMed ID: 8435878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
    Reznik Y; Chapon F; Lahlou N; Deboucher N; Mahoudeau J
    J Endocrinol Invest; 1997 Oct; 20(9):566-8. PubMed ID: 9413812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.
    Guerra Y; Lacuesta E; Marquez F; Raksin PB; Utset M; Fogelfeld L
    Pituitary; 2010; 13(1):54-9. PubMed ID: 19842040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer.
    Mastandrea K; Voica M; Tetlay M; Hasan F
    JCEM Case Rep; 2023 May; 1(3):luad069. PubMed ID: 37908581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.
    Guarda FJ; Yu X; Shiraliyeva N; Haines MS; Bradbury M; Saylor PJ; Nachtigall LB
    Pituitary; 2021 Oct; 24(5):681-689. PubMed ID: 33835355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a pituitary adenoma following treatment with a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
    Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
    Int J Urol; 2006 Jan; 13(1):87-8. PubMed ID: 16448441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.
    Dökmetaş HS; Selçuklu A; Colak R; Unlühizarci K; Bayram F; Keleştimur F
    J Endocrinol Invest; 1999 Oct; 22(9):698-700. PubMed ID: 10595834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.